文献速递前列腺癌

高危前列腺癌根治术中保留神经血管束与肿瘤学结局的关联

Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2020-08-19

该研究基于两家高容量中心2000-2017年数据库,纳入4351例D'Amico高危前列腺癌根治术患者,比较双侧、单侧与不保留神经血管束(NVB)的肿瘤学结局。结果显示,与不保留相比,双侧或单侧NVB保留在生化复发、转移和总生存方面均未增加风险,包括临床T3和/或活检ISUP 5级及病理T3亚组。

要点

  • 高危前列腺癌根治术中保留NVB未增加生化复发、转移或死亡风险。
  • 双侧NVB保留者120个月无生化复发率62.2%,不保留者27.1%。
  • 临床T3和/或活检ISUP 5级及病理T3亚组中,保留NVB仍安全。

核心结论

  • 在高危和/或局部晚期前列腺癌患者中,保留NVB与更差的肿瘤学结局无关。
  • 对于经过良好选择、存在非器官局限风险的患者,可考虑保留NVB。

研究设计与样本

  • 基于两家高容量中心数据库(2000-2017年)的回顾性队列研究。
  • 纳入4351例D'Amico高危前列腺癌根治术患者。

主要发现

  • 双侧、单侧和不保留NVB的患者比例分别为35.7%、38.0%和26.3%。
  • 术后120个月无生化复发率分别为62.2%、44.3%和27.1%(p < 0.001)。
  • 术后120个月无转移生存率分别为83.7%、66.7%和60.3%(p < 0.001)。
  • 术后120个月总生存率分别为91.8%、87.5%和72.3%(p < 0.001)。
  • 多变量Cox回归显示,与不保留NVB相比,双侧或单侧保留未增加生化复发、转移或死亡风险,全体队列及临床T3和/或活检ISUP 5级、病理T3亚组均一致。

临床怎么用

  • 在高危和/或局部晚期前列腺癌患者中,保留NVB不应被视为肿瘤学禁忌。
  • 对于经过良好选择、存在非器官局限风险的患者,可考虑保留NVB以改善功能结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the oncologic safety of neurovascular bundles (NVB) preservation at radical prostatectomy (RP) in patients with high-risk and/or locally advanced prostate cancer (PCa). MATERIAL AND METHODS: Within a two-institutional high-volume center database we identified patients who harbored high-risk PCa at RP (2000-2017). Only patients with D'Amico high-risk PCa were included. Kaplan-Meier and multivariable Cox regression models tested the effect of NVB preservation on biochemical recurrence (BCR), metastasis and overall survival (OS). Subgroup analyses focused on patients with clinical stage T3 and/or biopsy ISUP grade 5 and pathologic stage T3. RESULTS: Of 4351 patients with D'Amico high-risk, 35.7% vs. 38.0% vs. 26.3% underwent bilateral vs. unilateral vs. no NVB preservation, respectively. At 120 months after RP BCR-free, metastasis-free survival and OS rates were 62.2% vs. 44.3% vs. 27.1% (p < 0.001), 83.7% vs. 66.7% vs. 60.3% (p < 0.001), and 91.8% vs. 87.5% vs. 72.3% (p < 0.001) for bilateral vs. unilateral vs. no NVB preservation, respectively. In multivariable Cox regression models, bilateral and unilateral compared to no NVB preservation did not increase the risk for BCR, metastasis or death in the entire cohort and in subgroups with clinical stage T3 and/or biopsy ISUP grade 5, as well as pathologic stage T3. CONCLUSIONS: NVB preservation was not associated with worse oncological outcome in patients with high-risk and/or locally advanced PCa and may be offered to well-selected patients who are at risk of harboring nonorgan-confined PCa.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Preisser F, Gandaglia G, Arad F, et al. Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer. Prostate Cancer Prostatic Dis. 2020. PMID: 32814844. doi:10.1038/s41391-020-00266-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。